Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies.
about
Psychiatric disturbances associated with ganciclovir therapyMedical management of human immunodeficiency virus infection.Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipientsThe role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments.Clinically resistant cytomegalovirus retinitis.Medical and virological aspects of ocular human immunodeficiency virus infection for the ophthalmologist.Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients.Cytomegalovirus infection and cardiac allograft vasculopathy.HIV disease and the gastroenterologistLooking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection.Emerging therapies for herpes viral infections (types 1 - 8).Specific and non-specific serological markers in the screening for congenital CMV infectionIntestinal cytomegalovirus ganglioneuronitis in children with human immunodeficiency virus infection.Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies.Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections.Ocular involvement in AIDS.A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.Human immunodeficiency virus infection. Diagnostic and treatment issues in an expanding spectrum.Development of a quadriplex polymerase chain reaction for human cytomegalovirus detection.Thiazolo[4,5-d]pyrimidines. Part II. Synthesis and anti-human cytomegalovirus activity in vitro of certain acyclonucleosides and acyclonucleotides derived from the guanine analogue 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione.Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986Use of ganciclovir in the treatment of acquired cytomegalovirus disease in a preterm infantCytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger?Antiviral therapy. New drugs and their uses.Cytomegalovirus retinitis: diagnosis and treatment.Antiviral sensitivities of the acute retinal necrosis syndrome virus.Cytomegalovirus viremia in HIV-infected patients treated with zidovudine.Evolution of Intravitreal Therapy for Retinal Diseases - From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture.Time for capnography - everywhere.Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health EmergenciesAutopsy Findings in 47 Cases of Adult T-cell Leukemia/Lymphoma in Miyazaki Prefecture, Japan
P2860
Q28343080-C551D023-3420-405F-9FFE-C6B170E89A51Q30371489-5B78C6EB-B907-4BC4-8B27-D1013D232EBAQ33351296-E73D2FA9-78A1-4860-A839-1A37DC910CB8Q33400808-CC7F3FA6-F5EB-4152-93EA-8477946997AAQ33569554-39736A7D-E78B-472F-8082-263990244519Q33569593-804267BA-940A-4F9F-ACFF-B9F08F3BB5C2Q34240675-1DA24C46-AB78-4703-8283-0B0D3EB87796Q34294809-8E9E7470-F7DC-4400-8D8C-FB097C21049DQ34530800-8B63B556-FB60-4040-9B6A-62A3614ED2B7Q34998102-1FBBDE34-6767-4F2E-881F-6E6F489B6F10Q35967376-110E9487-FE3C-45DF-887F-0F4D39D4B63CQ36473109-F7A805E0-59EC-4BB9-B4D1-46F5E818A8F5Q37874430-40816B99-B3AA-4659-80B5-394456E80057Q37901418-2214EBDC-25D2-4347-96B8-862F291A666AQ38305554-198CB6C8-67CE-4CF0-948F-BD872D852804Q39581045-076C6975-581D-449F-9CA2-46F8A03AD510Q39594664-D2F5AFE6-DA06-4F60-8593-AF3D6EFD104CQ39759308-EDE88E5B-8949-4BCB-BD5C-AEEF79B31574Q40954786-0E539E91-59A1-44F6-A34A-DABC7D3ACFA3Q40983979-7DB823BA-4A68-435D-97A6-FFA20AC129D0Q42207181-E2A7B813-CCA6-4C20-AD87-2CABD15D4D06Q42263137-BF02DCE0-1718-4596-8828-1495A0EA55BCQ43546238-968B36B1-01CB-484F-A369-C3CF974194EBQ43669773-2D1ECD5C-F6D3-4731-B645-A97383CBAE6CQ44031712-A1C40D38-94C4-4564-AA44-EAFDAE892F44Q45835136-2947A062-370F-4FB5-A910-FE05585AB69AQ46071708-73E94BA5-30DD-43FE-B235-F91BD185D469Q47729194-43E8A80E-9A73-44E4-A691-5F99EB8EB6F2Q48259164-2C79D9F1-E085-4288-8F31-4E930AEAF104Q56481192-9FDDEBDF-4927-438C-894A-00DE2642AA67Q57646225-4C70BE3A-E8BB-4E3F-989F-B1C86D6E9CDC
P2860
Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Treatment of serious cytomegal ...... and other immunodeficiencies.
@en
Treatment of serious cytomegal ...... and other immunodeficiencies.
@nl
type
label
Treatment of serious cytomegal ...... and other immunodeficiencies.
@en
Treatment of serious cytomegal ...... and other immunodeficiencies.
@nl
prefLabel
Treatment of serious cytomegal ...... and other immunodeficiencies.
@en
Treatment of serious cytomegal ...... and other immunodeficiencies.
@nl
P1476
Treatment of serious cytomegal ...... and other immunodeficiencies.
@en
P2093
Collaborative DHPG Treatment Study Group
P304
P356
10.1056/NEJM198603273141301
P407
P577
1986-03-01T00:00:00Z